P4 Uncontrolled Gout AGILE
Research payments
$510,735
Through program year 2025, $510,735 in research payments was reported against P4 Uncontrolled Gout AGILE, across 43 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $56,975 | 6 |
| 2024 | Research | $453,760 | 37 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Orrin Troum Santa Monica, CA Named on 4 payments
- John Botson Wailea, HI Named on 4 payments
- Jigar Shah Margate, FL Named on 2 payments
- Kenneth Saag Birmingham, AL Named on 2 payments
- David Snow Leland, NC Named on 2 payments
- Abigail Neiman Houston, TX Named on 1 payment
- Dan La Tujunga, CA Named on 1 payment
- Christian Martin Shelby, NC Named on 1 payment
- Hillary Norton Santa Fe, NM Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.